Revenue ₹597 Cr
Promise tracking available after 2+ quarters of coverage.
View all executive profiles for Epigral LimitedEpigral's Q3 FY26 results were weak, with EBITDA margin contracting to 17% (vs 22% 9M average) due to lower realizati...
Quarterly Earnings Timeline
Financial verification status, call summary, sentiment, and management-delivery signals by quarter.